2017 annual report

Novocure U.S.
Novocure Jersey
Novocure Switzerland
Novocure Germany
Novocure Israel
Novocure Japan
Novocure Canada

explore our world

letter to our shareholders driving commercial adoption advancing our clinical pipeline building long-term shareholder value